From the Department of Emergency Medicine (J.W.M., J.H.K., J.C., I.P., J.H.B.).
Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics (H.Y.K.), Yonsei University College of Medicine, Seoul, Republic of Korea.
AJNR Am J Neuroradiol. 2020 Apr;41(4):632-636. doi: 10.3174/ajnr.A6472. Epub 2020 Mar 12.
The use of invasive cerebral angiography with CTA for active treatment of patients with suspected ischemic strokes has been increasing recently. This study aimed to identify the incidence of postcontrast acute kidney injury using baseline renal function when CTA and cerebral angiography were performed sequentially.
This retrospective observational study evaluated adults (18 years of age or older) with ischemic stroke who underwent CTA and cerebral angiography sequentially between 2010 and 2018. The incidence of postcontrast acute kidney injury was determined using the baseline estimated glomerular filtration rate. The value of the baseline estimated glomerular filtration rate at which the occurrence of postcontrast acute kidney injury increased was also determined.
Postcontrast acute kidney injury occurred in 57/601 (9.5%) patients. Those with a baseline estimated glomerular filtration rate of <30 mL/min/1.73 m showed a higher incidence of acute kidney injury. Age, chronic kidney disease, medication (nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, β blockers, statins, and insulin) use following contrast media exposure, and serum albumin affected the incidence of postcontrast acute kidney injury. The incidence of postcontrast acute kidney injury increased when the baseline estimated glomerular filtration rate was <43 mL/min/1.73 m.
Patients with low baseline renal function had the highest incidence of postcontrast acute kidney injury after CTA and cerebral angiography, but no fatal adverse effects were documented. Thus, patients suspected of having a stroke should be actively managed with respect to neurovascular function.
最近,使用 CTA 进行有创性脑血管造影术对疑似缺血性脑卒中患者进行积极治疗的情况有所增加。本研究旨在当 CTA 和脑血管造影术连续进行时,根据基线肾功能确定使用 CTA 后对比剂急性肾损伤的发生率。
本回顾性观察性研究评估了 2010 年至 2018 年间连续接受 CTA 和脑血管造影术的缺血性脑卒中成年患者(18 岁或以上)。使用基线估算肾小球滤过率确定使用 CTA 后对比剂急性肾损伤的发生率。还确定了导致使用 CTA 后对比剂急性肾损伤发生率增加的基线估算肾小球滤过率值。
57/601(9.5%)例患者发生使用 CTA 后对比剂急性肾损伤。基线估算肾小球滤过率<30ml/min/1.73m 者急性肾损伤发生率较高。年龄、慢性肾脏病、药物(非甾体抗炎药、血管紧张素转换酶抑制剂、血管紧张素 II 受体阻滞剂、β受体阻滞剂、他汀类药物和胰岛素)使用、造影剂暴露后血清白蛋白影响使用 CTA 后对比剂急性肾损伤的发生率。当基线估算肾小球滤过率<43ml/min/1.73m 时,使用 CTA 后对比剂急性肾损伤的发生率增加。
低基线肾功能患者在 CTA 和脑血管造影术后发生对比剂急性肾损伤的发生率最高,但未记录到致命的不良影响。因此,疑似脑卒中的患者应积极进行神经血管功能管理。